Advanced search×

Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis.

R R Agarwal, A N AN Aggarwal, D D Gupta, and S K SK Jindal

Int J Tuberc Lung Dis 13(8):936-44 (2009) PMID 19723372

The prevalence of Aspergillus hypersensitivity (AH) and allergic bronchopulmonary aspergillosis (ABPA) in bronchial asthma is reported differently in various studies.

Version: za2963e q8za9 q8zb0 q8zc1 q8zd1 q8ze3 q8zfd q8zgd

Similar articles you may find interesting…

  1. Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis.
    A J AJ Nunn, A A Jindani, ...

    Int J Tuberc Lung Dis 15(6):741-5 (2011) PMID 21575292

    These results confirm earlier findings demonstrating the inferiority of the INH+EMB-based regimens to the standard 6-month regimen. The WHO has withdrawn its recommendation of these regimens....
  2. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and 2 integrin-dependent cell clearance program
    N Maugeri, P Rovere-Querini, ... A A Manfredi

    Blood 113(21):5254-5265 (2009) PMID 19264679

    We show that the ensuing cell-to-cell interaction programs neutrophil phagocytic function, resulting in activated platelet clearance. Neutrophils that have internalized platelets circulate in the blood of patients with acute myocardial infarction, and the extent of platelet clearance correlates with...
  3. Immunosuppression in pancreas transplantation: the Euro SPK trials and beyond.
    J J Malaise, A A De Roover, ...

    Acta Chir Belg 108(6):673-8 (2008) PMID 19241916

    The Immunosuppression in Pancreas Transplantation was historically based on the fact that the pancreas is an extremely immunogenic organ. Quadruple drug therapy with polyclonal or monoclonal antibodies induction was the mainstay therapy since the introduction of Cyclosporine A. In the modern era of...